Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jan 29;12(2):211.
doi: 10.3390/pathogens12020211.

Supporting the Aspecific Physiological Defenses of Upper Airways against Emerging SARS-CoV-2 Variants

Luca Cegolon  1   2 , Giuseppe Mastrangelo  3 , Saverio Bellizzi  4 , Francesca Larese Filon  1   2 , Cristiano Salata  5
Affiliations
Editorial

Supporting the Aspecific Physiological Defenses of Upper Airways against Emerging SARS-CoV-2 Variants

Luca Cegolon et al. Pathogens. .

Abstract

The rapid rollout of COVID-19 vaccines in 2021 sparked general optimism toward controlling the severe form of the disease, preventing hospitalizations and COVID-19-associated mortality, and the transmissibility of SARS-CoV-2 infection [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael A., Creech C.B., et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Marc G.P., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. N. Engl. J. Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577. - DOI - PMC - PubMed
    1. Voysey M., Costa Clemens S.A., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., Angus B., Baillie V.L., Barnabas S.L., Bhorat Q.E., et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: A pooled analysis of four randomised trials. Lancet. 2021;397:881–891. doi: 10.1016/S0140-6736(21)00432-3. - DOI - PMC - PubMed
    1. Pires L., Wilson B.C., Bremner R., Lang A., Larouche J., McDonald R., Pearson J.D., Trcka D., Wrana J., Wu J., et al. Translational feasibility and efficacy of nasal photodynamic disinfection of SARS-CoV-2. Sci. Rep. 2022;12:14438. doi: 10.1038/s41598-022-18513-0. - DOI - PMC - PubMed
    1. Cegolon L., Negro C., Mastrangelo g Larese Filon F. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021–31 May 2022. Viruses. 2022;14:2688. doi: 10.3390/v14122688. - DOI - PMC - PubMed

Publication types

LinkOut - more resources